Treatments for symptomatic urinary tract infections during pregnancy

Juan C Vazquez; José Villar

doi:10.1002/14651858.CD002256

Scolaris Content Display Scolaris Content Display

Contenido relacionado

Ir a:

Revisiones y protocolos relacionados
Guías
Temas

Revisiones y protocolos relacionados

Topics

Temas

Analysis 1.1

Comparison 1 Intravenous + oral antibiotics versus intravenous only, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 1.2

Comparison 1 Intravenous + oral antibiotics versus intravenous only, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.1

Comparison 2 Outpatient versus inpatient antibiotics, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.2

Comparison 2 Outpatient versus inpatient antibiotics, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.3

Comparison 2 Outpatient versus inpatient antibiotics, Outcome 3 Preterm delivery.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.5

Comparison 2 Outpatient versus inpatient antibiotics, Outcome 5 Admission to neonatal intensive care unit.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.6

Comparison 2 Outpatient versus inpatient antibiotics, Outcome 6 Need for change antibiotic.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 2.7

Comparison 2 Outpatient versus inpatient antibiotics, Outcome 7 Incidence of prolonged pyrexia.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 3.1

Comparison 3 Intravenous cephazolin versus intravenous ampicillin + gentamicin, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 3.2

Comparison 3 Intravenous cephazolin versus intravenous ampicillin + gentamicin, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 3.3

Comparison 3 Intravenous cephazolin versus intravenous ampicillin + gentamicin, Outcome 3 Preterm delivery.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 3.5

Comparison 3 Intravenous cephazolin versus intravenous ampicillin + gentamicin, Outcome 5 Admission to neonatal intensive care unit.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 3.6

Comparison 3 Intravenous cephazolin versus intravenous ampicillin + gentamicin, Outcome 6 Need for change antibiotic.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 3.7

Comparison 3 Intravenous cephazolin versus intravenous ampicillin + gentamicin, Outcome 7 Incidence of prolonged pyrexia.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 4.1

Comparison 4 Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 4.2

Comparison 4 Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 4.3

Comparison 4 Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin, Outcome 3 Preterm delivery.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 4.5

Comparison 4 Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin, Outcome 5 Admission to neonatal intensive care unit.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 4.6

Comparison 4 Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin, Outcome 6 Need for change antibiotic.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 4.7

Comparison 4 Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin, Outcome 7 Incidence of prolonged pyrexia.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 5.1

Comparison 5 Intramuscular ceftriaxone versus intravenous cephazolin, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 5.2

Comparison 5 Intramuscular ceftriaxone versus intravenous cephazolin, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 5.3

Comparison 5 Intramuscular ceftriaxone versus intravenous cephazolin, Outcome 3 Preterm delivery.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 5.5

Comparison 5 Intramuscular ceftriaxone versus intravenous cephazolin, Outcome 5 Admission to neonatal intensive care unit.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 5.6

Comparison 5 Intramuscular ceftriaxone versus intravenous cephazolin, Outcome 6 Need for change antibiotic.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 5.7

Comparison 5 Intramuscular ceftriaxone versus intravenous cephazolin, Outcome 7 Indicence of prolonged pyrexia.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 6.1

Comparison 6 Cephalosporins once‐a‐day versus multiple doses, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 6.2

Comparison 6 Cephalosporins once‐a‐day versus multiple doses, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 6.3

Comparison 6 Cephalosporins once‐a‐day versus multiple doses, Outcome 3 Preterm delivery.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 6.6

Comparison 6 Cephalosporins once‐a‐day versus multiple doses, Outcome 6 Need for change antibiotic.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 6.8

Comparison 6 Cephalosporins once‐a‐day versus multiple doses, Outcome 8 Birthweight < 2500 g.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 6.9

Comparison 6 Cephalosporins once‐a‐day versus multiple doses, Outcome 9 Intrauterine growth retardation.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 7.1

Comparison 7 Oral ampicillin versus oral nitrofurantoin, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 7.2

Comparison 7 Oral ampicillin versus oral nitrofurantoin, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 7.6

Comparison 7 Oral ampicillin versus oral nitrofurantoin, Outcome 6 Need for change antibiotic.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 8.1

Comparison 8 Intravenous and oral cephradine versus intravenous and oral cefuroxime, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 8.2

Comparison 8 Intravenous and oral cephradine versus intravenous and oral cefuroxime, Outcome 2 Recurrent infection.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 9.1

Comparison 9 Oral fosfomicin trometamol versus oral ceftibuten, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Analysis 10.1

Comparison 10 Single versus multiple dose of gentamicin, Outcome 1 Cure rates.

Ir a la figura de la revisiónAbrir en una pestaña nueva

Comparison 1. Intravenous + oral antibiotics versus intravenous only

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	67	Peto Odds Ratio (Peto, Fixed, 95% CI)	2.43 [0.46, 12.90]

2 Recurrent infection Show forest plot	1	67	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.81 [0.45, 7.31]

3 Preterm delivery	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Premature rupture of membranes	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Need for change antibiotic	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Incidence of prolonged pyrexia	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]

Comparison 1. Intravenous + oral antibiotics versus intravenous only

Ir a la tabla de la revisión

Comparison 2. Outpatient versus inpatient antibiotics

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	2	212	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.46 [0.55, 3.92]

2 Recurrent infection Show forest plot	2	212	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.66 [0.19, 2.34]

3 Preterm delivery Show forest plot	2	204	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.05 [0.32, 3.49]

4 Premature rupture of membranes	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit Show forest plot	1	84	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.72 [0.21, 2.42]

6 Need for change antibiotic Show forest plot	2	212	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.85 [0.28, 2.60]

7 Incidence of prolonged pyrexia Show forest plot	1	120	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.13 [0.02, 0.94]

Comparison 2. Outpatient versus inpatient antibiotics

Ir a la tabla de la revisión

Comparison 3. Intravenous cephazolin versus intravenous ampicillin + gentamicin

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	120	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.26 [0.28, 5.77]

2 Recurrent infection Show forest plot	1	107	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.56 [0.34, 7.19]

3 Preterm delivery Show forest plot	1	107	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.97 [0.47, 8.29]

4 Premature rupture of membranes	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit Show forest plot	1	107	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.50 [0.57, 3.95]

6 Need for change antibiotic Show forest plot	1	118	Peto Odds Ratio (Peto, Fixed, 95% CI)	7.78 [0.48, 125.98]

7 Incidence of prolonged pyrexia Show forest plot	1	120	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.70 [0.19, 2.53]

Comparison 3. Intravenous cephazolin versus intravenous ampicillin + gentamicin

Ir a la tabla de la revisión

Comparison 4. Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	121	Peto Odds Ratio (Peto, Fixed, 95% CI)	3.29 [0.55, 19.58]

2 Recurrent infection Show forest plot	1	109	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.10 [0.21, 5.68]

3 Preterm delivery Show forest plot	1	109	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.10 [0.21, 5.68]

4 Premature rupture of membranes	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit Show forest plot	1	109	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.59 [0.62, 4.11]

6 Need for change antibiotic Show forest plot	1	121	Peto Odds Ratio (Peto, Fixed, 95% CI)	8.19 [1.13, 59.68]

7 Incidence of prolonged pyrexia Show forest plot	1	121	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.06 [0.32, 3.46]

Comparison 4. Intramuscular ceftriaxone versus intravenous ampicillin + gentamicin

Ir a la tabla de la revisión

Comparison 5. Intramuscular ceftriaxone versus intravenous cephazolin

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	117	Peto Odds Ratio (Peto, Fixed, 95% CI)	2.84 [0.39, 20.70]

2 Recurrent infection Show forest plot	1	102	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.71 [0.15, 3.26]

3 Preterm delivery Show forest plot	1	102	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.56 [0.13, 2.36]

4 Premature rupture of membranes	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit Show forest plot	1	102	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.06 [0.42, 2.68]

6 Need for change antibiotic Show forest plot	1	117	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.97 [0.38, 10.12]

7 Indicence of prolonged pyrexia Show forest plot	1	117	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.51 [0.42, 5.51]

Comparison 5. Intramuscular ceftriaxone versus intravenous cephazolin

Ir a la tabla de la revisión

Comparison 6. Cephalosporins once‐a‐day versus multiple doses

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	178	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.72 [0.42, 7.09]

2 Recurrent infection Show forest plot	1	122	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.72 [0.16, 3.27]

3 Preterm delivery Show forest plot	1	178	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.11 [0.41, 3.01]

4 Premature rupture of membranes	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Need for change antibiotic Show forest plot	1	178	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.58 [0.14, 2.39]

7 Incidence of prolonged pyrexia	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
8 Birthweight < 2500 g Show forest plot	1	178	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.13 [0.39, 3.24]

9 Intrauterine growth retardation Show forest plot	1	178	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.77 [0.20, 2.95]

Comparison 6. Cephalosporins once‐a‐day versus multiple doses

Ir a la tabla de la revisión

Comparison 7. Oral ampicillin versus oral nitrofurantoin

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	86	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.79 [0.21, 2.93]

2 Recurrent infection Show forest plot	1	86	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.58 [0.50, 4.96]

3 Preterm delivery	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Premature rupture of membranes	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Need for change antibiotic Show forest plot	1	86	Peto Odds Ratio (Peto, Fixed, 95% CI)	1.25 [0.21, 7.61]

7 Incidence of prolonged pyrexia	0	0	Peto Odds Ratio (Peto, Fixed, 95% CI)	0.0 [0.0, 0.0]

Comparison 7. Oral ampicillin versus oral nitrofurantoin

Ir a la tabla de la revisión

Comparison 8. Intravenous and oral cephradine versus intravenous and oral cefuroxime

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	101	Odds Ratio (M‐H, Fixed, 95% CI)	0.39 [0.16, 0.93]

2 Recurrent infection Show forest plot	1	101	Odds Ratio (M‐H, Fixed, 95% CI)	2.57 [1.07, 6.17]

3 Preterm delivery	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Premature rupture of membranes	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Need for change antibiotic	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Incidence of prolonged pyrexia	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]

Comparison 8. Intravenous and oral cephradine versus intravenous and oral cefuroxime

Ir a la tabla de la revisión

Comparison 9. Oral fosfomicin trometamol versus oral ceftibuten

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	41	Odds Ratio (M‐H, Fixed, 95% CI)	2.22 [0.19, 26.63]

2 Recurrent infection	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Preterm delivery	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Premature rupture of membranes	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Need for change antobiotic	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Incidence of prolonged pyrexia	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]

Comparison 9. Oral fosfomicin trometamol versus oral ceftibuten

Ir a la tabla de la revisión

Comparison 10. Single versus multiple dose of gentamicin

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Cure rates Show forest plot	1	106	Odds Ratio (M‐H, Fixed, 95% CI)	0.24 [0.01, 5.17]

2 Recurrent infection	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Preterm delivery	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Premature rupture of membranes	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
5 Admission to neonatal intensive care unit	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Need for change antibiotic	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
7 Incidence of prolonged pyrexia	0	0	Odds Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]

Comparison 10. Single versus multiple dose of gentamicin

Ir a la tabla de la revisión

The Cochrane Library

Scolaris Language Selector Scolaris Language Selector

Idioma de la Revisión Cochrane

Idioma de la web

Scolaris Content Language Banner Portlet Scolaris Content Language Banner Portlet

Scolaris Content Display Scolaris Content Display

Temas

Scolaris Language Selector Scolaris Language Selector

Scolaris Content Display Scolaris Content Display

Instituciones a las que se accedió previamente

Scolaris Content Display Scolaris Content Display

Usuarios institucionales

Instituciones a las que se accedió previamente

Otras opciones de acceso

	Idioma de la Revisión Cochrane Escoja su idioma de preferencia para las revisiones Cochrane y otros contenidos. Las secciones sin una traducción aparecerán en inglés.

	Idioma de la web Escoja su idioma de preferencia para la web de la Biblioteca Cochrane.

Idioma de la Revisión Cochrane

Idioma de la web

Contenido relacionado

Revisiones y protocolos relacionados

Temas

Copiar o descargar referencia

Idioma de la Revisión Cochrane

Idioma de la web

Instituciones a las que se accedió previamente

Usuarios institucionales

Instituciones a las que se accedió previamente

Otras opciones de acceso